Statins, Fibrates, and Melanoma Risk: a Systematic Review and Meta-analysis

Background: Large randomized, controlled clinical trials of lovastatin and gemfibrozil for heart disease prevention have reported statistically significantly lower melanoma incidences in persons receiving these medications. Results of in vitro animal model and human case–control studies also suggest...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2006-11, Vol.98 (21), p.1538-1546
Hauptverfasser:	Freeman, Scott R., Drake, Amanda L., Heilig, Lauren F., Graber, Marla, McNealy, Kristie, Schilling, Lisa M., Dellavalle, Robert P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Atorvastatin Calcium Bezafibrate - therapeutic use Biological and medical sciences Clinical trials Clofibrate - therapeutic use Dermatology Gemfibrozil - therapeutic use Heptanoic Acids - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypolipidemic Agents - therapeutic use Incidence Lovastatin - therapeutic use Medical sciences Melanoma - epidemiology Melanoma - prevention & control Meta-analysis Odds Ratio Pravastatin - therapeutic use Pyrroles - therapeutic use Randomized Controlled Trials as Topic Reproducibility of Results Simvastatin - therapeutic use Skin cancer Skin Neoplasms - epidemiology Skin Neoplasms - prevention & control Statins Tumors Tumors of the skin and soft tissue. Premalignant lesions United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!